BioControl vs Nucleix

BioControl vs Nucleix, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BioControl is on 42/100 and Nucleix on 56/100.

BioControlBioControl develops advanced diagnostic solutions for infectious diseases and cancer.
Try BioControl
Nucleix logo
NucleixNucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.
Try Nucleix

Where each one leads

BioControl

Leads on none of the measures we hold for both companies.

Nucleix

  • our overall score: 56/100 against 42/100
  • agent readiness: 30/100 against 21/100
  • domain rating: 38/100 against 20/100

At a glance

MeasureBioControlNucleix
What it isBioControl develops advanced diagnostic solutions for infectious diseases and cancer.Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.
CategoryHealthcare, HealthTech, MedTech, BiotechHealthcare, Lung, Bladder, Cancer
Sells toBusiness modelB2BB2B
OfferingSoftwareSoftware
Founded19992008
HeadquartersCucamonga, United StatesRehovot, Israel
StatusActiveActive

Size, funding and growth

MeasureBioControlNucleix
EmployeesNot published74
Headcount growthLast 12 monthsNot published+7.1%
Total funding$76.0M$88.0M
Latest roundStrategicFunding Round
LinkedIn followersNot published7,846

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureBioControlNucleix
StartupHub scoreOur 0-100 rating42/10056/100
Traction39/10059/100
TeamNot published70/100
Search visibility6/10036/100
Quality58/10055/100
Agent readinessHow well an AI agent can read and act on the siteF (21/100)F (30/100)
Domain ratingLink authority, 0-10020/10038/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureBioControlNucleix
CDNNot detectedCloudflare
CMSNot detectedWordPress
FrameworksNot detectedJquery
AnalyticsNot detectedGoogle Analytics 4

What users say

MeasureBioControlNucleix
Reddit sentimentThreads we trackNot published6 positive, 0 negative across 6 threads
Nucleix
Nucleix Demonstrates Potential of its PCR EpiCheck® Assay to Accurately Differentiate Between Small Cell Lung Cancer (SCLC) Subtypes.
r/LungCancerSupport

BioControl vs Nucleix: common questions

Which is better, BioControl or Nucleix?

On our 0-100 score Nucleix rates higher (56/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.

How do BioControl and Nucleix compare on the numbers?

Nucleix leads on our overall score (56/100 against 42/100), agent readiness (30/100 against 21/100), domain rating (38/100 against 20/100).

What do real users say about BioControl and Nucleix?

Nucleix: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/LungCancerSupport.

Read the full BioControl review and pricing or the Nucleix review and pricing. You can also browse other BioControl alternatives we track.